M. Reichel

Prognostic factors in the operative treatment of ductal pancreatic carcinoma

C. Gebhardt, W. Meyer, M. Reichel, 2000, Langenbeck's Archives of Surgery.

Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas

C. Gebhardt, W. Meyer, M. Reichel, 2010, Surgery Today.

[Color-coded duplex sonography and ultrasound contrast medium in the study of peripheral arteries--initial clinical experiences].

K. Wolf, M. Reichel, I. Ohnesorge, 2008, Ultraschall in der Medizin.

[Superparamagnetic iron particles. The clinical results in the MR diagnosis of liver metastases].

T. Vogl, M. Taupitz, K. Wolf, 1994, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

Conventional vs accelerated fractionation in head and neck cancer.

W. Millesi, G. Wilson, E. Dobrowsky, 1996, The British journal of cancer. Supplement.

Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer.

W. Millesi, J. Widder, E. Dobrowsky, 1998, International journal of radiation oncology, biology, physics.

T2-weighted breath-hold MR imaging of the liver at 1.5 T: results with a three-dimensional steady-state free precession sequence in 87 patients.

B Hamm, M Deimling, K J Wolf, 1995, Radiology.

Mitomycin C (MMC) and unconventional fractionation (V-CHART) in advanced head and neck cancer.

W. Millesi, E. Dobrowsky, J. Naude, 1995, Acta oncologica.

c Chemical Sensitizers and Protecters CONTINUOUS HYPERFRACTIONATED ACCELERATED RADIOTHERAPY WITH/WITHOUT MITOMYCIN C IN HEAD AND NECK CANCER

W. Millesi, J. Widder, E. Dobrowsky, 1998 .

2118 Continuous hyperfractionated accelerated radiation therapy with/without mitomycin C in head and neck cancer: Initial results from an on-going randomized trial

M. Schemper, W. Millesi, E. Dobrowsky, 1996 .